Skip to content

    Recently Viewed


      Home /



      How advances in HIV treatment could help young people living with HIV

      We spoke to a scientist behind a treatment for the disease that was recently FDA-approved for adolescents ages 12 to 18 to learn how it could give them new hope.
      Latest news
      A young child taking medication

      Improving access to medicine around the world

      Johnson & Johnson earned the #2 spot on the Access to Medicine Index, an important measurement of the company’s longstanding commitment to make lifesaving medicine available and accessible to those who need it most.
      Left to right: Joss J. De Wet, M.D., Johnson & Johnson's Brian Woodfall, M.D., and artist Tiko Kerr

      Meet 3 men who’ve been on the front lines of HIV treatments for decades

      Johnson & Johnson’s Brian Woodfall, M.D., was working at a Vancouver clinic in the mid-1990s. That’s where he met Tiko Kerr, who became one of the first patients to take the company’s HIV medicines—and has thrived to this day. For National AIDS Awareness Month, watch as Kerr, Dr. Woodfall and fellow researcher Joss J. De Wet, M.D., reflect on how those treatments have saved lives and continue to evolve, in this moving video.
      Woman shows dapivirine ring to three young women

      This ring may just help protect women against HIV

      As the International AIDS Conference kicks off, learn how a new tool will help give this group greater power to prevent HIV on a monthly basis.
      Lifesaving drone being observed by many onlookers in a field

      How drones are being used to deliver lifesaving HIV drugs to remote areas of the world

      Normally, in this part of Uganda, medication is delivered by boat—a slow, difficult process. But now a new Johnson & Johnson-supported program is using drones that can serve 20 landing sites across five islands, reaching more than 3,700 people in a single day.
      Personal stories
      Group of kids in matching uniforms smiling and laughing

      “1.5 million children are living with HIV in sub-Saharan Africa. I’m one of the doctors treating these young patients every day”

      A relaunched Johnson & Johnson partnership will help ensure that many young patients get lifesaving access to HIV medicines. Meet a doctor in Kenya who explains why the program is so crucial.
      Doctor in personal protection equipment holding a blood sample in a vial

      How Johnson & Johnson has pioneered in the battle against HIV/AIDS

      For World AIDS Day, we look at the groundbreaking strides the company has made—and continues to make—toward a world without the disease.
      Latest news
      Lede-Johnson & Johnson Named a 2021 Fortune World’s Most Admired Company.jpg

      Johnson & Johnson named a 2021 Fortune World’s Most Admired Company

      The company is proud to have placed in the top 20 on the prestigious list for its commitment to innovation, dedication to social responsibility and the quality of its products, among other noteworthy attributes—all in the face of a global pandemic.
      Latest news
      Scientists holding petri dish that looks like it contains a world map

      4 ways Johnson & Johnson has worked to make access to medicines around the world more equitable

      The Access to Medicine Index, a ranking of pharmaceutical companies’ work to distribute medications to low- and middle-income countries, just named Johnson & Johnson #3 on its biennial list, underscoring the company’s deep history of ensuring people in underserved communities receive the treatments they need.
      Illustration of seven ways Johnson & Johnson is advancing healthcare floating above a sun setting on the horizon

      “My 2021 healthcare resolution": 7 Johnson & Johnson leaders share their goals for advancing healthcare and health equity

      A potential COVID-19 vaccine. Passionate efforts toward achieving racial and social justice. Smarter, more sustainable product packaging. These are just a few of the resolutions company change makers are aiming to bring to light this year—and they’re already hard at work on them.